| Income Statement |
| Total Revenue | 213.99M |
|
| Revenues (USD) | 213.99M |
| Cost of Revenue | 63.04M |
| Gross Profit | 150.94M |
| Operating Expenses | 130.78M |
| Research and Development Expense | 37.13M |
| Selling, General and Administrative Expense | 87.08M |
| Operating Income | 20.16M |
| Income Tax Expense | 5.74M |
| Net Income | 17.52M |
| Net Income Common Stock | 17.52M |
| Net Income Common Stock (USD) | 17.52M |
| Consolidated Income | 17.52M |
| Earnings per Basic Share | 0.29 |
| Earnings per Basic Share (USD) | 0.29 |
| Earnings per Diluted Share | 0.28 |
| Earning Before Interest & Taxes (EBIT) | 23.25M |
| Earning Before Interest & Taxes (USD) | 23.25M |
| Weighted Average Shares | 60.09M |
| Balance Sheet |
| Cash and Equivalents | 363.52M |
| Cash and Equivalents (USD) | 363.52M |
| Investments | 7.50M |
| Investments Current | 7.50M |
| Trade and Non-Trade Receivables | 216.71M |
| Current Assets | 635.68M |
| Property, Plant & Equipment Net | 5.38M |
| Total Assets | 1.28B |
| Current Liabilities | 239.24M |
| Total Liabilities | 301.41M |
| Accumulated Retained Earnings (Deficit) | 1.48B |
| Accumulated Other Comprehensive Income | 5.61M |
| Shareholders Equity | 977.40M |
| Shareholders Equity (USD) | 977.40M |
| Assets Non-Current | 643.13M |
| Deferred Revenue | 45.27M |
| Goodwill and Intangible Assets | 508.44M |
| Liabilities Non-Current | 62.18M |
| Trade and Non-Trade Payables | 128.65M |
| Tax Assets | 64.19M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.33M |
| Net Cash Flow from Financing | -32.32M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.02M |
| Capital Expenditure | -703.00K |
| Issuance (Purchase) of Equity Shares | -32.32M |
| Net Cash Flow from Investing | -703.00K |
| Net Cash Flow from Operations | 17.02M |
| Effect of Exchange Rate Changes on Cash | -13.00K |
| Share Based Compensation | 20.94M |